查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球遠端保健和遠端醫療市場（至 2030 年）：按功能（遠距會診、RPM、診斷和治療、分析、管理）、應用（遠距 ICU、遠距放射學、循環系統、糖尿病）、最終用戶（醫院、ASC、付款人）和地區分類
市場調查報告書
商品編碼
1660113

全球遠端保健和遠端醫療市場（至 2030 年）：按功能（遠距會診、RPM、診斷和治療、分析、管理）、應用（遠距 ICU、遠距放射學、循環系統、糖尿病）、最終用戶（醫院、ASC、付款人）和地區分類

Telehealth & Telemedicine Market by Function (Teleconsultation, RPM, Diagnostics & Treatment, Analytics, Administrative), Application (TelelCU, Teleradiology, Telecardiology, Diabetes), End User (Hospital, ASC, Payer), & Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 501 Pages | 訂單完成後即時交付

價格

遠端保健和遠端醫療市場規模預計將從 2024 年的 941.4 億美元成長到 2030 年的 1,808.6 億美元，2024 年至 2030 年的複合年成長率為 11.5%。

遠端保健和遠端醫療市場正在迅速擴張，原因有很多，包括通訊技術的進步、政府支持和監管政策以及遠端患者監護系統的擴展。人口老化需要持續監測慢性疾病，從而增加了對具有成本效益的醫療保健解決方案的需求。此外，糖尿病、心血管疾病等慢性病的發病率上升也凸顯了遠距醫療的價值。遠端醫療可以節省大量時間和金錢，對患者和醫療保健提供者都具有吸引力。遠距病患監測技術的日益普及和通訊技術的進步正在提高虛擬護理的成功率和市場採用率，而政府透過優惠的監管和報銷框架提供的支持也促進了市場的擴大。

研究範圍
調查年份 2024-2030
基準年 2023
預測期 2024-2030
單元 金額（美元）
部分 組件、功能、用途、年齡層、最終用戶、地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

“基於最終用戶，預計患者群體在預測期內將呈現最高成長。”

這主要是由於遠距醫療服務的日益普及，患者可以在舒適的家中接受諮詢和治療。促成這一成長的其他因素包括慢性病的增加、對便捷及時的醫療保健的需求以及對遠端醫療益處的認知不斷提高。新冠疫情也加速了遠端醫療的發展，病患尋求比面對面預約更安全的替代方案。提高病患舒適度、降低醫療成本、改善專家服務（尤其是在農村和服務不足地區）也被視為成長推進因素。

“從組成部分來看，軟體部門將佔有最大的佔有率。”

這是因為遠端醫療平台在虛擬諮詢、遠端患者監護和電子健康記錄管理方面的使用增加。醫療保健提供者越來越廣泛地使用數位資源以更有效的方式提供醫療服務，其中視訊會議、預約安排、安全通訊和資料分析軟體很快就變得至關重要。人工智慧和機器學習與遠端醫療應用軟體的整合，透過提供增強的診斷能力、個人化的臨床管理和更好的患者治療結果，加速了市場擴張。此外，醫療保健系統之間的無縫互通性以及對資料安全和隱私監管合規性的日益關注也進一步刺激了對先進遠距遠端醫療軟體的需求。

“預計亞太地區將在預測期內實現最高複合年成長率”

亞太地區正受益於快速發展的醫療保健基礎設施和數位技術的進步。這是由多種因素造成的，包括數位醫療產品的使用增加、人口成長和老化帶來的醫療保健需求以及慢性病盛行率的增加。此外，印度和中國等地區的網路和行動普及率不斷提高也加速了遠端醫療服務的成長。政府推動遠端醫療的措施和數位醫療基礎設施的改善也對該市場的成長發揮了促進作用。

本報告調查了全球遠端保健和遠端醫療市場，並提供了市場概況摘要、影響市場成長的各種因素分析、技術和專利趨勢、法律制度、案例研究、市場規模趨勢和預測、各個細分市場、地區和主要國家的詳細分析、競爭格局以及主要企業的概況。

目錄

第 1 章 簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章 市場概況

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
    • 任務
  • 影響我們客戶業務的趨勢/中斷
  • 產業趨勢
  • 生態系分析
  • 價值鏈分析
  • 技術分析
  • 資費和監管分析
  • 貿易分析
  • 定價分析
  • 波特五力分析
  • 主要相關利益者和採購標準
  • 專利分析
  • 未滿足的需求和最終用戶的期望
  • 重要會議及活動
  • 案例研究分析
  • 投資金籌措場景
  • 經營模式分析
  • 人工智慧/生成式人工智慧對遠端保健和遠端醫療市場的影響
  • 還款情境分析

第6章遠端保健和遠端醫療市場（按組件）

  • 硬體
    • 遠端醫療套件、推車和站點
    • 病患監測設備
  • 軟體
    • 按方式
    • 按整合類型
    • 按類型
    • 按安裝
  • 服務

第 7 章遠端保健與遠端醫療市場（按功能）

  • 臨床護理管理
  • 預防保健管理
  • 診斷和治療
  • 遠端患者監護/病患監測
  • 復健與恢復
  • 行政
  • 分析和報告
  • 病人參與
  • 其他

第 8 章遠端保健與遠端醫療市場（按應用）

  • 基層醫療
  • 專業護理
    • 遠端輻射
    • 遠距循環系統護理
    • 遠距神經病學
    • 糖尿病
    • 呼吸系統疾病
    • 高血壓
    • 遠距皮膚科
    • 遠距中風治療
    • 遠距精神科護理
    • 其他
  • 遠距重症監護室
  • 虛擬護理
  • 其他

第 9 章遠端保健與遠端醫療市場（按年齡層）

  • 孩子們
  • 成人
  • 老年病學

第 10 章遠端保健和遠端醫療市場（按最終用戶分類）

  • 醫療保健提供者
    • 醫院
    • 門診手術中心、門診護理中心和其他門診設施
    • 長期照護及輔助生活設施
    • 家庭保健
    • 其他
  • 醫療支付者
    • 公共保險公司
    • 私人保險公司
  • 病人
  • 製藥和生物技術公司
  • 醫療科技公司
  • 其他

第 11 章遠端保健與遠端醫療市場（按地區）

  • 北美洲
    • 宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 宏觀經濟展望
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 宏觀經濟展望
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他
  • 拉丁美洲
    • 宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 宏觀經濟展望
    • 海灣合作理事會國家
    • 其他

第12章 競爭格局

  • 主要參與企業的策略/優勢
  • 收益分析
  • 市場佔有率
  • 企業評估矩陣：主要企業
  • 公司估值矩陣：Start-Ups/小型企業
  • 估值及財務指標
  • 品牌/軟體比較分析
  • 競爭場景

第13章 公司簡介

  • 主要企業
    • MEDTRONIC
    • TELADOC HEALTH, INC.
    • CISCO SYSTEMS, INC.
    • KONINKLIJKE PHILIPS NV
    • ZOOM COMMUNICATIONS, INC.
    • GE HEALTHCARE
    • EPIC SYSTEMS CORPORATION
    • ORACLE
    • DOXIMITY, INC.
    • AMERICAN WELL
    • SIEMENS HEALTHINEERS AG
    • INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.)
    • AMC HEALTH
    • TELESPECIALISTS
    • WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.)
    • CAREGILITY
    • CVS HEALTH
    • EVERNORTH HEALTH, INC.
    • ELATION
    • IRON BOW TECHNOLOGIES
  • 其他公司
    • TIMEDOC, INC.
    • CEREBRAL INC.
    • KINDBODY
    • TRANSCARENT
    • CARESIMPLE INC.

第14章 附錄

Product Code: HIT 3542

The telehealth and telemdicine market is projected to reach USD 180.86 billion by 2030 from USD 94.14 billion in 2024, at a CAGR of 11.5% from 2024 to 2030. The telehealth and telemedicine market is rapidly expanding due to a variety of factors such as advancement in telecommunication technologies, government support and regulatory policies, and expansion of remote patient moniytoring systems. An aging population necessitates continuous monitoring of chronic conditions, creating a growing demand for cost-effective healthcare solutions. Furthermore, the rising prevalence of chronic diseases, such as diabetes and cardiovascular disease, emphasizes the value of remote care. Telemedicine saves a lot of time and money, hence becoming attractive for both patients and providers. The advancements in the field of telecommunications technology along with the increasing adoption of remote patient monitored technologies have enhanced the virtual care success rate and market adoption, while government support through favorable regulation and reimbursable frameworks has helped in market expansion.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2023
Forecast Period2024-2030
Units ConsideredValue (USD)
SegmentsComponent, Function, Application, Age Group, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East Africa

"Patients segment had the fastest growth rate in the telehealth & telemedicine market during the forecast period, by end user."

By end user, the patients segment is the fastest growing segment in the telehealth and telemedicine market during the forecast period. This is mainly due to the growing adoption of remote healthcare services, which enable patients to receive medical consultations and treatment from the comfort of their own homes. The factors that have contributed to the increase include growing chronic conditions, the need for convenient and timely medical care, and the increasing awareness of the benefits of telemedicine. The COVID-19 pandemic had also been an accelerator of telehealth, with patients seeking safer alternatives to in-person visits. Other factors that are driving this market segment include enhanced patient comfort, reduced healthcare costs, and improved access to specialists, especially in rural or underserved areas.

"By component, software segment to accounted for the largest market share in the telehealth and telemedicine market."

Based on component, the software segment accounted for the largest market share in the telehealth and telemedicine market. This is due to the increase in the use of telehealth platforms for virtual consultation, remote patient monitoring, and electronic health record management. With use of digital resources by healthcare providers becoming widespread in delivering care in an efficient manner, software for video conferencing, appointment scheduling, secure messaging and data analytics, are fast becoming critical. The integration of artificial intelligence (AI) and machine learning in telemedicine application software also is accelerateing market expansion, providing enhanced diagnostic capabilities, tailored clinical management, and better outcomes for the patient. Moreover, the rising focus on seamless interoperability between healthcare systems and regulatory compliance for data security and privacy further accelerates the demand for advanced telehealth software.

"Asia Pacific is estimated to register the fastest CAGR over the forecast period."

The telehealth & telemdicine market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific telehealth & telemdicine market is projected to register fastest CAGR during the forecast period. The Asia Pacific is benefiting from the fast-developing healthcare infrastructure, advances in digital technologies. It is due to multiple factors such as the rising use of digital healthcare products, healthcare needs resulting from large and ageing populations, as well as an increasing incidence of chronic diseases. Moreover, internet penetration and mobile penetration have broadened in areas such as India and China, which in turn have accelerated the growth in telehealth services. Government activities promoting telemedicine and improvements in digital health infrastructure also play a role in contributing to the growth of telehealth and telemedicine market.

Breakdown of supply-side primary interviews by company type, designation, and region:

  • By Company Type: Tier 1 (40%), Tier 2 (35%), and Tier 3 (25%)
  • By Designation: Managers (40%), Directors (35%), and Others (25%)
  • By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%) and Middle East & Africa (2%)

List of Companies Profiled in the Report:

1. Koninklijke Philips N.V. (Netherlands)

2. Medtronic (Ireland)

3. GE Healthcare (US)

4. Epic Systems Corporation (US)

5. Oracle (US)

6. Doximity, Inc. (US)

7. Teladoc Health, Inc. (US)

8. American Well (US)

9. Siemens Healthineers AG (Germany)

10. Cisco Systems Inc. (US)

11. Included Health, Inc. (Doctor on Demand, Inc.) (US)

12. AMC Health (US)

13. TeleSpecialists (US)

14. Walgreen Co. (US)

15. Caregility (US)

16. CVS Health (US)

17. EverNorth Health, Inc. (US)

18. Elation (US)

19. Iron Bow Healthcare Solutions (US)

20. ZoomCommunications, Inc. (US)

21. Timedoc Health (US)

22. Cerebral Inc. (US)

23. Kindbody (US)

24. Transcarent (US)

25. Caresimple, Inc. (US)

Research Coverage:

This research report categorizes the telehealth & telemedicine market by component (Hardware (Telehealth Kits, Carts, And Stations, Patient Monitoring Devices (Cardiac Monitoring Devices, Neurological Monitoring Devices, Respiratory Monitoring Devices, Blood Glucose Monitoring Devices, Fetal & Neonatal Monitoring Devices, Weight Monitoring Devices, Multiparameter Monitoring Devices, Pulse Oximeter Devices, Other Monitoring Devices)), Software (By Modality: EHR Centric, Non-EHR Centric, By Integration Type: Integrated Software, Standalone Software, By Type: Remote Patient Monitoring, Virtual Care Platforms (Real-Time Interaction, Store & Forward), Video Conferencing platforms, Virtual sitting & Nursing, By Deployment: On-premise model, Cloud-based model), and Services). By Function (Clinical Care Management (Including Teleconsultation & Follow-Up), Preventive Care Management, Diagnostics & Treatment, Remote Patient Monitoring/Patient Monitoring, Rehabilitation & Recovery, Administrative, Analytics & Reporting, Patient Engagement, Other Functions (Clinical Trials, Education, Training, and Others), By Application (Primary Care, Speciality Care (Teleradiology, Telecardiology, Teleneurology, Diabetes, Respiratory Disorders (COPD, Asthma, And Others), Hypertension, Teledermatology, Telestroke, Telepsychiatry (Mental Health), Others (Dental, Oncology, Obstetrics, Gynaecology, Ophthalmology, Metabolic Disorders, Immunology, Gastroenterology, Nephrology & Urology, Rare Disease, Infectious Diseases, And Others), TeleICU, Virtual Sitting & Nursing, Other Applications (Clinical Trials, Emergency & Urgent Care, General Wellness & Lifestyle Improvement, Occupational Health, and Others), By Age Group (Pediatrics, Adults, Geriatrics), By End User (Healthcare Providers (Hospitals, Ambulatory Surgical Centers, Ambulatory Care Centers, and Other Outpatient Settings, Long Term Care & Assisted Living Facilities, Home Healthcare, Other Healthcare Providers (Diagnostics & Imagining Centers, Rehabilitation Centers, Behavioural Health Centers, and Others), Healthcare Payers (Public Payers, Private Payers), Patients, Pharmaceutical & Biotechnology Companies, Medtech Companies, Other End Users (Medtech Companies, Academic Institutes, Research Centers, Government Organizations, and Others)) and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the telehealth & telemedicine market. A thorough analysis of the key industry players has been done to provide insights into their business overview, offerings, and key strategies such as acquisitions, collaborations, partnerships, mergers, product/service launches & enhancements, and approvals in the telehealth & telemedicine market. Competitive analysis of upcoming startups in the telehealth & telemedicine market ecosystem is covered in this report.

Reasons to Buy the Report

The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall telehealth & telemedicine market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers: (Growing geriatric population and increasing need to expand healthcare access, Rising prevalence of chronic conditions, Demonstrated Time and Cost Savings, Advancements in telecommunication technologies, Shortage of skilled healthcare professionals, Government support & Regulatory policies, Expansion of Remote Patient Monitoring (RPM) systems), restraints (High investment costs and lack of IT expertise, Regulatory variations across regions, Behavioral reluctance to adopt new technologies, Rise in fraud and abuse within healthcare systems, Patient privacy and confidentiality, adhering to medical ethics), opportunities (Growing use of wearables, apps, and sensors for virtual care, Emergence of AI/ML, Increasing shift towards outpatient care models, High utility of telemedicine against infectious diseases and epidemics, Expansion of hospital-at-home initiatives, Demand for EMR-based telehealth, Rapid growth of mental health care), and challenges (Data security concerns, Limited data accessibility, Inability to maintain hygiene and cleanliness standards) influencing the growth of the telehealth & telemedicine market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the telehealth & telemedicine market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the telehealth & telemedicine market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the telehealth & telemedicine market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), Teladoc Health, Inc. (US), etc. among others in telehealth & telemedicine market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 TELEHEALTH
    • 1.2.2 TELEMEDICINE
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION & GEOGRAPHICAL SPREAD
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key sources of secondary data
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key sources of primary data
      • 2.1.2.2 Key objectives of primary research
      • 2.1.2.3 Key data from primary sources
      • 2.1.2.4 Insights from primary experts
  • 2.2 RESEARCH APPROACH
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 REVENUE SHARE ANALYSIS (SUPPLY-SIDE ANALYSIS)
    • 2.3.2 BOTTOM-UP APPROACH (END-USER ADOPTION)
    • 2.3.3 TOP-DOWN APPROACH
    • 2.3.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
  • 2.4 DATA TRIANGULATION
  • 2.5 MARKET SHARE ESTIMATION
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS
  • 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 TELEHEALTH & TELEMEDICINE MARKET OVERVIEW
  • 4.2 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER AND REGION
  • 4.3 TELEHEALTH & TELEMEDICINE MARKET: GEOGRAPHIC SNAPSHOT
  • 4.4 TELEHEALTH & TELEMEDICINE MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing geriatric population and increasing need for advanced healthcare infrastructure
      • 5.2.1.2 Rising prevalence of chronic diseases
      • 5.2.1.3 Reduced time and lower out-of-pocket costs
      • 5.2.1.4 Advancements in telecommunication technologies
      • 5.2.1.5 Shortage of skilled healthcare professionals
      • 5.2.1.6 Increased government support and favorable regulatory policies
      • 5.2.1.7 Expansion of remote patient monitoring systems
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High investment costs for B2B models and lack of IT expertise
      • 5.2.2.2 State-to-state and inter-country regulatory variations
      • 5.2.2.3 Behavioral reluctance to adopt new technologies
      • 5.2.2.4 Rise in fraud and abuse in healthcare systems
      • 5.2.2.5 Adherence to patient privacy, confidentiality, medical ethics
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing use of wearables, applications, and sensors for virtual care
      • 5.2.3.2 Emergence of AI and ML
      • 5.2.3.3 Increasing shift toward outpatient care models
      • 5.2.3.4 High utility of telemedicine against infectious communicable diseases and epidemics
      • 5.2.3.5 Expansion of hospital-at-home (HaH) initiatives
      • 5.2.3.6 Demand for electronic medical record-based telehealth services
      • 5.2.3.7 Rising incidence of mental illnesses and growing focus on emotional well-being
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Data security and confidentiality concerns
      • 5.2.4.2 Limited data accessibility
      • 5.2.4.3 Inability to maintain patient hygiene and cleanliness standards
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • 5.4 INDUSTRY TRENDS
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 TECHNOLOGY ANALYSIS
    • 5.7.1 KEY TECHNOLOGIES
      • 5.7.1.1 Video conferencing and real-time communication platforms
      • 5.7.1.2 AI and ML
      • 5.7.1.3 Virtual assistants and chatbots
      • 5.7.1.4 Voice recognition and natural language processing
      • 5.7.1.5 EHR integration
      • 5.7.1.6 Remote patient monitoring systems
    • 5.7.2 COMPLEMENTARY TECHNOLOGIES
      • 5.7.2.1 Edge computing
      • 5.7.2.2 Cloud computing
      • 5.7.2.3 Mobile health (mHealth) applications
      • 5.7.2.4 Wearable devices, sensors, and IoT
    • 5.7.3 ADJACENT TECHNOLOGIES
      • 5.7.3.1 Digital therapeutics
      • 5.7.3.2 Blockchain technology
      • 5.7.3.3 Augmented reality and virtual reality
  • 5.8 TARIFF AND REGULATORY ANALYSIS
    • 5.8.1 TARIFF DATA ANALYSIS
      • 5.8.1.1 Tariff data for HS code 9018
      • 5.8.1.2 Tariff data for HS code 9021
      • 5.8.1.3 Tariff data for HS code 9022
    • 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.8.3 REGULATORY STANDARDS
    • 5.8.4 REGULATORY FRAMEWORK
  • 5.9 TRADE ANALYSIS
    • 5.9.1 TRADE DATA FOR HSN CODE 90189099
      • 5.9.1.1 Top 10 importers for HSN code 90189099
      • 5.9.1.2 Top 10 exporters for HSN code 90189099
    • 5.9.2 TRADE DATA FOR HSN CODE 9021
      • 5.9.2.1 Top 10 importers for HSN code 9021
      • 5.9.2.2 Top 10 exporters for HSN code 9021
    • 5.9.3 TRADE DATA FOR HSN CODE 9022
      • 5.9.3.1 Top 10 importers for HSN code 9022
      • 5.9.3.2 Top 10 exporters for HSN code 9022
  • 5.10 PRICING ANALYSIS
    • 5.10.1 INDICATIVE PRICING FOR TELEHEALTH & TELEMEDICINE SOLUTIONS, BY COMPONENT, 2023
    • 5.10.2 INDICATIVE PRICING OF TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2023
    • 5.10.3 PRICING MODELS
  • 5.11 PORTER'S FIVE FORCES ANALYSIS
    • 5.11.1 THREAT OF NEW ENTRANTS
    • 5.11.2 THREAT OF SUBSTITUTES
    • 5.11.3 BARGAINING POWER OF BUYERS
    • 5.11.4 BARGAINING POWER OF SUPPLIERS
    • 5.11.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.12.2 KEY BUYING CRITERIA
  • 5.13 PATENT ANALYSIS
    • 5.13.1 PATENT PUBLICATION TRENDS FOR TELEHEALTH & TELEMEDICINE
    • 5.13.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.14 UNMET NEEDS & END-USER EXPECTATIONS
    • 5.14.1 UNMET NEEDS
    • 5.14.2 END-USER EXPECTATIONS
  • 5.15 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.16 CASE STUDY ANALYSIS
    • 5.16.1 TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH TEBRA'S INTEGRATED SOLUTIONS
    • 5.16.2 USE OF TELEHEALTH TO REDUCE PREVENTABLE EMERGENCY ROOM TRANSFERS FROM SKILLED NURSING FACILITIES
    • 5.16.3 CONE HEALTH TO REVOLUTIONIZE TELEHEALTH FOR TRANSITION TO CAREGILITY'S UNIVERSAL HEALTH ENGAGEMENT SOLUTIONS
  • 5.17 INVESTMENT & FUNDING SCENARIO
  • 5.18 BUSINESS MODEL ANALYSIS
    • 5.18.1 DIRECT-TO-PATIENT (D2P) MODEL
    • 5.18.2 BUSINESS-TO-BUSINESS (B2B) MODEL
    • 5.18.3 EMPLOYER-SPONSORED MODEL
    • 5.18.4 SUBSCRIPTION-BASED MODEL
    • 5.18.5 HYBRID TELEMEDICINE MODEL
    • 5.18.6 PLATFORM-AS-A-SERVICE (PAAS) MODEL
    • 5.18.7 VALUE-BASED CARE MODEL
  • 5.19 IMPACT OF AI/GEN AI IN TELEHEALTH & TELEMEDICINE MARKET
    • 5.19.1 KEY USE CASES
    • 5.19.2 MAJOR CASE STUDIES
      • 5.19.2.1 AI to redefine treatment effectiveness and safety
      • 5.19.2.2 AI-driven chatbots and telehealth to enhance mental health and chronic disease management
    • 5.19.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
      • 5.19.3.1 Healthcare IT and EHR systems
      • 5.19.3.2 Pharmaceuticals & drug discovery
      • 5.19.3.3 Mental health tech
      • 5.19.3.4 Healthcare analytics and insights
    • 5.19.4 USER READINESS & IMPACT ASSESSMENT
      • 5.19.4.1 User readiness
        • 5.19.4.1.1 User A: Hospitals
        • 5.19.4.1.2 User B: Ambulatory surgery centers
      • 5.19.4.2 Impact assessment
        • 5.19.4.2.1 User A: Hospitals
        • 5.19.4.2.2 User B: Ambulatory surgery centers
  • 5.20 REIMBURSEMENT SCENARIO ANALYSIS

6 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT

  • 6.1 INTRODUCTION
  • 6.2 HARDWARE
    • 6.2.1 TELEHEALTH KITS, CARTS, AND STATIONS
      • 6.2.1.1 Increased focus on streamlined workflows and quality of remote healthcare services to drive adoption
    • 6.2.2 PATIENT MONITORING DEVICES
      • 6.2.2.1 Cardiac monitoring devices
        • 6.2.2.1.1 Cardiac monitoring telehealth devices to minimize need for frequent hospital visits and improve patient outcomes
      • 6.2.2.2 Neurological monitoring devices
        • 6.2.2.2.1 Focus on better neuro care with advanced telemedicine solutions to augment segment growth
      • 6.2.2.3 Respiratory monitoring devices
        • 6.2.2.3.1 Rising prevalence of respiratory diseases and demand for home-based healthcare to drive segment
      • 6.2.2.4 Blood glucose monitoring devices
        • 6.2.2.4.1 Increasing number of diabetic patients in low- and middle-income countries to augment need for remote monitoring
      • 6.2.2.5 Fetal & neonatal monitoring devices
        • 6.2.2.5.1 Focus on continuous and personalized care without frequent in-person visits to drive segment
      • 6.2.2.6 Weight monitoring devices
        • 6.2.2.6.1 Rising prevalence of obesity and increasing awareness about weight management to drive market
      • 6.2.2.7 Multiparameter monitoring devices
        • 6.2.2.7.1 Rise of home healthcare and increased demand for remote patient monitoring to propel segment growth
      • 6.2.2.8 Pulse oximeter devices
        • 6.2.2.8.1 Remote pulse oximeter devices to manage chronic respiratory conditions and help faster patient recovery
      • 6.2.2.9 Other patient monitoring devices
  • 6.3 SOFTWARE
    • 6.3.1 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY
      • 6.3.1.1 EHR-centric software
        • 6.3.1.1.1 EHR-centric software to improve patient information accessibility and secure sharing across platforms
      • 6.3.1.2 Non-EHR-centric software
        • 6.3.1.2.1 Non-EHR-centric software to conduct virtual consultations and facilitate telehealth services without constraints
    • 6.3.2 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE
      • 6.3.2.1 Integrated software
        • 6.3.2.1.1 Integrated software to streamline clinical workflow and promote better access to patient health data
      • 6.3.2.2 Standalone software
        • 6.3.2.2.1 Increased focus on flexibility and ease of usage to fuel adoption
    • 6.3.3 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE
      • 6.3.3.1 Remote patient monitoring platforms
        • 6.3.3.1.1 Increased popularity of at-home chronic disease management among geriatric patients to aid market growth
      • 6.3.3.2 Virtual care platforms
        • 6.3.3.2.1 Real-time interaction platforms
          • 6.3.3.2.1.1 Synchronous nature and better healthcare access to drive segment
        • 6.3.3.2.2 Store & forward platforms
          • 6.3.3.2.2.1 Easy monitoring of vital signs for long-term chronic care without physical presence to fuel segment growth
      • 6.3.3.3 Video conferencing platforms
        • 6.3.3.3.1 Need for collaborative and coordinated care for chronic patients to augment segment growth
      • 6.3.3.4 Virtual sitting & nursing platforms
        • 6.3.3.4.1 Reduced workload of on-site staff and prevention of costly hospital readmissions to boost segment growth
    • 6.3.4 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT
      • 6.3.4.1 On-premise deployment models
        • 6.3.4.1.1 Enhanced control and safety of inventory data with better reuse of existing infrastructure to drive market
      • 6.3.4.2 Cloud-based deployment models
        • 6.3.4.2.1 Need to integrate information from disparate locations in real time for database registry to drive segment
  • 6.4 SERVICES
    • 6.4.1 COST-EFFECTIVENESS AND REDUCED STRAIN ON HEALTHCARE PROVIDERS TO DRIVE MARKET

7 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION

  • 7.1 INTRODUCTION
  • 7.2 CLINICAL CARE MANAGEMENT
    • 7.2.1 FOCUS ON REAL-TIME CONSULTATIONS, PROACTIVE MONITORING, AND FOLLOW-UP STRATEGIES TO DRIVE MARKET
  • 7.3 PREVENTIVE CARE MANAGEMENT
    • 7.3.1 PREVENTIVE CARE AMONG RURAL PATIENTS TO REDUCE DELAYED DIAGNOSIS AND IMPROVE PATIENT ENGAGEMENT
  • 7.4 DIAGNOSTICS & TREATMENT
    • 7.4.1 DIAGNOSIS & TREATMENT TO SUPPORT PROACTIVE CARE MANAGEMENT AND DEVELOP PERSONAL HEALTHCARE PLANS
  • 7.5 REMOTE PATIENT MONITORING/PATIENT MONITORING
    • 7.5.1 REMOTE PATIENT MONITORING TO REVOLUTIONIZE PATIENT CARE BY IMPROVING ACCESSIBILITY, EFFICIENCY, AND HEALTH OUTCOMES
  • 7.6 REHABILITATION & RECOVERY
    • 7.6.1 ADOPTION OF TELEREHABILITATION TO OVERCOME REGIONAL BARRIERS AND SUPPORT PATIENTS WITH MOBILITY CHALLENGES
  • 7.7 ADMINISTRATIVE
    • 7.7.1 EFFICIENT ADMINISTRATIVE TASKS TO ENHANCE WORKFLOW AND IMPROVE OPERATIONAL EFFICIENCY
  • 7.8 ANALYTICS & REPORTING
    • 7.8.1 ADVANCED DATA ANALYTICS & REPORTING TO SUPPORT PROACTIVE DECISION-MAKING AND FOSTER BETTER CARE COORDINATION
  • 7.9 PATIENT ENGAGEMENT
    • 7.9.1 PROACTIVE PATIENT ENGAGEMENT TO PROMOTE ADHERENCE TO TREATMENT PLANS AND ENABLE TIMELY INTERVENTIONS
  • 7.10 OTHER FUNCTIONS

8 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 PRIMARY CARE
    • 8.2.1 TECHNOLOGICAL ADVANCEMENTS AND CONVENIENT ACCESS TO HEALTHCARE FACILITIES TO AID MARKET GROWTH
  • 8.3 SPECIALTY CARE
    • 8.3.1 TELERADIOLOGY
      • 8.3.1.1 Rise of cloud-based imaging solutions and AI-driven radiology tools to boost segment growth
    • 8.3.2 TELECARDIOLOGY
      • 8.3.2.1 Integration of AI, cloud-based ECG monitoring, and wearable health devices to fuel segment growth
    • 8.3.3 TELENEUROLOGY
      • 8.3.3.1 High prevalence of neurological disorders and incorporation of AI into diagnostic tools to spur segment growth
    • 8.3.4 DIABETES
      • 8.3.4.1 Rise in consumer demand for more accessible and cost-effective healthcare services to augment market growth
    • 8.3.5 RESPIRATORY DISORDERS
      • 8.3.5.1 Increasing global prevalence of chronic respiratory conditions among older adults to fuel market growth
    • 8.3.6 HYPERTENSION
      • 8.3.6.1 Need for continuous monitoring and rise of remote care technologies to propel market growth
    • 8.3.7 TELEDERMATOLOGY
      • 8.3.7.1 High prevalence of skin cancer and dermatology-related diseases to augment segment growth
    • 8.3.8 TELESTROKE
      • 8.3.8.1 Rising incidence of stroke and increasing geriatric population to drive market
    • 8.3.9 TELEPSYCHIATRY
      • 8.3.9.1 Shortage of mental health practitioners and poor access to psychiatric care in rural areas to fuel market growth
    • 8.3.10 OTHER SPECIALTY CARE APPLICATIONS
  • 8.4 TELEICU
    • 8.4.1 INCREASED EMERGENCY DEPARTMENT VISITS AND UNEVEN DISTRIBUTION OF SPECIALISTS TO SUPPORT MARKET GROWTH
  • 8.5 VIRTUAL SITTING & NURSING
    • 8.5.1 INCREASING DEMAND FOR HOME-BASED HEALTHCARE SERVICES TO FUEL MARKET GROWTH
  • 8.6 OTHER APPLICATIONS

9 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP

  • 9.1 INTRODUCTION
  • 9.2 PEDIATRICS
    • 9.2.1 INCREASING DEMAND FOR ACCESSIBLE AND CONVENIENT HEALTHCARE FOR CHILDREN IN RURAL AREAS TO DRIVE MARKET
  • 9.3 ADULTS
    • 9.3.1 HIGH DEMAND FOR REMOTE ROUTINE CHECK-UPS AND CHRONIC DISEASE MANAGEMENT TO PROPEL MARKET GROWTH
  • 9.4 GERIATRICS
    • 9.4.1 RISING GERIATRIC POPULATION TO AUGMENT NEED FOR REMOTE MEDICAL CONSULTATIONS

10 TELEHEALTH & TELEMEDICINE MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HEALTHCARE PROVIDERS
    • 10.2.1 HOSPITALS
      • 10.2.1.1 Increasing demand for advanced and high-quality to drive market
    • 10.2.2 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS
      • 10.2.2.1 High preference, minimized patient downtime, and reduced hospital stay to augment segment growth
    • 10.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES
      • 10.2.3.1 Need for prolonged treatment for chronic diseases and preference for participatory and preventive care to drive segment
    • 10.2.4 HOME HEALTHCARE
      • 10.2.4.1 Rising prevalence of chronic diseases and need for cost-effective solutions to aid market growth
    • 10.2.5 OTHER HEALTHCARE PROVIDERS
  • 10.3 HEALTHCARE PAYERS
    • 10.3.1 PUBLIC HEALTHCARE PAYERS
      • 10.3.1.1 Increasing healthcare R&D investments and favorable policies to drive segment
    • 10.3.2 PRIVATE HEALTHCARE PAYERS
      • 10.3.2.1 Implementation of telehealth services for mental health issues and substance usage to drive segment
  • 10.4 PATIENTS
    • 10.4.1 RISING GERIATRIC POPULATION TO INCREASE FOCUS ON TELEHEALTH SERVICES FOR LONG-TERM CARE NEEDS
  • 10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 10.5.1 RISE OF VIRTUAL CONSULTATIONS AND TELEMEDICINE PLATFORMS TO INCREASE CLINICAL TRIALS WITHOUT REGIONAL BARRIERS
  • 10.6 MEDTECH COMPANIES
    • 10.6.1 INCREASED DEMAND FOR INNOVATIVE HEALTHCARE DEVICES FOR REMOTE DIAGNOSIS AND TREATMENT TO AID MARKET GROWTH
  • 10.7 OTHER END USERS

11 TELEHEALTH & TELEMEDICINE MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 US to dominate North American telehealth & telemedicine market during study period
    • 11.2.3 CANADA
      • 11.2.3.1 Push for digital health integration to drive higher adoption of telehealth services
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 GERMANY
      • 11.3.2.1 Favorable government legislation for digitalized healthcare to spur market growth
    • 11.3.3 UK
      • 11.3.3.1 Increased government focus on digital health solutions to aid market growth
    • 11.3.4 FRANCE
      • 11.3.4.1 Strategic investments and government policy reforms to fuel uptake of digital medical devices for treatment
    • 11.3.5 ITALY
      • 11.3.5.1 Increased government healthcare investments to foster greater efficiency and accessibility in digital health solutions
    • 11.3.6 SPAIN
      • 11.3.6.1 Developed eHealth sector and increased adoption of wearable health tracking devices to augment market growth
    • 11.3.7 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 CHINA
      • 11.4.2.1 Investments in digital healthcare solutions to drive market
    • 11.4.3 JAPAN
      • 11.4.3.1 Favorable legal revisions and advancements in video and audio communication to aid market growth
    • 11.4.4 INDIA
      • 11.4.4.1 Ongoing digital transformation initiatives through favorable government schemes to support market adoption
    • 11.4.5 AUSTRALIA
      • 11.4.5.1 Significant government investments in rural, remote, and specialist aged care services to fuel uptake
    • 11.4.6 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 11.5.2 BRAZIL
      • 11.5.2.1 Increased availability of smartphones and improved internet connectivity to propel market growth
    • 11.5.3 MEXICO
      • 11.5.3.1 Regulatory improvements in telemedicine consultations to boost market growth
    • 11.5.4 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 11.6.2 GCC COUNTRIES
      • 11.6.2.1 Shortage of healthcare workforce to drive adoption of telehealth services
    • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN TELEHEALTH & TELEMEDICINE MARKET
  • 12.3 REVENUE ANALYSIS, 2019-2023
  • 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 12.5.5.1 Company footprint
      • 12.5.5.2 Region footprint
      • 12.5.5.3 Function footprint
      • 12.5.5.4 Application footprint
      • 12.5.5.5 Component footprint
      • 12.5.5.6 End-user footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 12.6.5.1 Detailed list of key startups/SMEs
      • 12.6.5.2 Competitive benchmarking of key startups/SMEs
  • 12.7 COMPANY VALUATION & FINANCIAL METRICS
  • 12.8 BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT LAUNCHES & APPROVALS
    • 12.9.2 DEALS
    • 12.9.3 EXPANSIONS
    • 12.9.4 OTHER DEVELOPMENTS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 MEDTRONIC
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products/Services/Solutions offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Product launches & approvals
        • 13.1.1.3.2 Deals
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Right to win
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses & competitive threats
    • 13.1.2 TELADOC HEALTH, INC.
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products/Services/Solutions offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Product launches & enhancements
        • 13.1.2.3.2 Deals
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Right to win
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses & competitive threats
    • 13.1.3 CISCO SYSTEMS, INC.
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products/Services/Solutions offered
      • 13.1.3.3 MnM view
        • 13.1.3.3.1 Right to win
        • 13.1.3.3.2 Strategic choices
        • 13.1.3.3.3 Weaknesses & competitive threats
    • 13.1.4 KONINKLIJKE PHILIPS N.V.
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products/Services/Solutions offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Product launches & approvals
        • 13.1.4.3.2 Deals
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Right to win
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses & competitive threats
    • 13.1.5 ZOOM COMMUNICATIONS, INC.
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products/Services/Solutions offered
      • 13.1.5.3 Recent developments
        • 13.1.5.3.1 Deals
      • 13.1.5.4 MnM view
        • 13.1.5.4.1 Right to win
        • 13.1.5.4.2 Strategic choices
        • 13.1.5.4.3 Weaknesses & competitive threats
    • 13.1.6 GE HEALTHCARE
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products/Services/Solutions offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Product launches & approvals
        • 13.1.6.3.2 Deals
    • 13.1.7 EPIC SYSTEMS CORPORATION
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products/Services/Solutions offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Product launches & enhancements
        • 13.1.7.3.2 Deals
    • 13.1.8 ORACLE
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products/Services/Solutions offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Product launches
        • 13.1.8.3.2 Deals
    • 13.1.9 DOXIMITY, INC.
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products/Services/Solutions offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Product enhancements
        • 13.1.9.3.2 Deals
        • 13.1.9.3.3 Other developments
    • 13.1.10 AMERICAN WELL
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products/Services/Solutions offered
      • 13.1.10.3 Recent developments
        • 13.1.10.3.1 Product launches
        • 13.1.10.3.2 Deals
        • 13.1.10.3.3 Other developments
    • 13.1.11 SIEMENS HEALTHINEERS AG
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products/Services/Solutions offered
      • 13.1.11.3 Recent developments
        • 13.1.11.3.1 Product launches & approvals
        • 13.1.11.3.2 Deals
    • 13.1.12 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.)
      • 13.1.12.1 Business overview
      • 13.1.12.2 Products/Services/Solutions offered
      • 13.1.12.3 Recent developments
        • 13.1.12.3.1 Deals
        • 13.1.12.3.2 Other developments
    • 13.1.13 AMC HEALTH
      • 13.1.13.1 Business overview
      • 13.1.13.2 Products/Services/Solutions offered
      • 13.1.13.3 Recent developments
        • 13.1.13.3.1 Deals
    • 13.1.14 TELESPECIALISTS
      • 13.1.14.1 Business overview
      • 13.1.14.2 Products/Services/Solutions offered
      • 13.1.14.3 Recent developments
        • 13.1.14.3.1 Product launches
        • 13.1.14.3.2 Deals
        • 13.1.14.3.3 Other developments
    • 13.1.15 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.)
      • 13.1.15.1 Business overview
      • 13.1.15.2 Products/Services/Solutions offered
      • 13.1.15.3 Recent developments
        • 13.1.15.3.1 Product launches
        • 13.1.15.3.2 Deals
        • 13.1.15.3.3 Expansions
    • 13.1.16 CAREGILITY
      • 13.1.16.1 Business overview
      • 13.1.16.2 Products/Services/Solutions offered
      • 13.1.16.3 Recent developments
        • 13.1.16.3.1 Product launches
        • 13.1.16.3.2 Deals
        • 13.1.16.3.3 Other developments
    • 13.1.17 CVS HEALTH
      • 13.1.17.1 Business overview
      • 13.1.17.2 Products/Services/Solutions offered
      • 13.1.17.3 Recent developments
        • 13.1.17.3.1 Product launches
        • 13.1.17.3.2 Deals
    • 13.1.18 EVERNORTH HEALTH, INC.
      • 13.1.18.1 Business overview
      • 13.1.18.2 Products/Services/Solutions offered
      • 13.1.18.3 Recent developments
        • 13.1.18.3.1 Deals
    • 13.1.19 ELATION
      • 13.1.19.1 Business overview
      • 13.1.19.2 Products/Services/Solutions offered
      • 13.1.19.3 Recent developments
        • 13.1.19.3.1 Deals
    • 13.1.20 IRON BOW TECHNOLOGIES
      • 13.1.20.1 Business overview
      • 13.1.20.2 Products/Services/Solutions offered
  • 13.2 OTHER PLAYERS
    • 13.2.1 TIMEDOC, INC.
    • 13.2.2 CEREBRAL INC.
    • 13.2.3 KINDBODY
    • 13.2.4 TRANSCARENT
    • 13.2.5 CARESIMPLE INC.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 TELEHEALTH & TELEMEDICINE MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 TELEHEALTH & TELEMEDICINE MARKET: STUDY ASSUMPTIONS
  • TABLE 3 TELEHEALTH & TELEMEDICINE MARKET: RISK ASSESSMENT
  • TABLE 4 MARKET DYNAMICS: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • TABLE 5 CHRONIC DISEASES AND RELATED COST BURDEN IN US
  • TABLE 6 RECENT DEVELOPMENTS IN REMOTE PATIENT MONITORING SYSTEMS, JANUARY 2023-JANUARY 2025
  • TABLE 7 US: STATE-WISE REGULATORY REQUIREMENTS FOR TELEHEALTH
  • TABLE 8 TOP 30 HEALTHCARE DATA BREACHES IN US, 2011-2024
  • TABLE 9 INDUSTRY TRENDS IN TELEHEALTH & TELEMEDICINE MARKET
  • TABLE 10 OVERVIEW OF TELEHEALTH USE CASES
  • TABLE 11 TELEHEALTH & TELEMEDICINE MARKET: ROLE IN ECOSYSTEM
  • TABLE 12 AVERAGE TARIFF FOR HS CODE 9018, 2023
  • TABLE 13 AVERAGE TARIFF FOR HS CODE 9021, 2023
  • TABLE 14 AVERAGE TARIFF FOR HS CODE 9022, 2023
  • TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 TELEHEALTH & TELEMEDICINE MARKET: REGULATORY STANDARDS
  • TABLE 19 REGULATORY REQUIREMENTS IN NORTH AMERICA
  • TABLE 20 REGULATORY REQUIREMENTS IN EUROPE
  • TABLE 21 REGULATORY REQUIREMENTS IN ASIA PACIFIC
  • TABLE 22 REGULATORY REQUIREMENTS IN LATIN AMERICA
  • TABLE 23 REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA
  • TABLE 24 TOP 10 IMPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 25 TOP 10 EXPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 26 TOP 10 IMPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 27 TOP 10 EXPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 28 TOP 10 IMPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 29 TOP 10 EXPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 30 COST RANGE INVOLVED IN TELEMEDICINE DEVICES (USD)
  • TABLE 31 INDICATIVE PRICING FOR TELEHEALTH & TELEMEDICINE SOLUTIONS, BY COMPONENT, 2023
  • TABLE 32 AVERAGE SELLING PRICE OF TELADOC CONSULTATIONS, 2023
  • TABLE 33 INDICATIVE PRICING OF TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2023
  • TABLE 34 TELEHEALTH & TELEMEDICINE MARKET: PORTER'S FIVE FORCES
  • TABLE 35 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE
  • TABLE 36 KEY BUYING CRITERIA FOR TOP THREE COMPONENTS
  • TABLE 37 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR TELEHEALTH & TELEHEALTH
  • TABLE 38 UNMET NEEDS IN TELEHEALTH & TELEMEDICINE MARKET
  • TABLE 39 END-USER EXPECTATIONS IN TELEHEALTH & TELEMEDICINE MARKET
  • TABLE 40 TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
  • TABLE 41 CASE 1: TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH TEBRA'S INTEGRATED SOLUTIONS
  • TABLE 42 CASE 2: USE OF TELEHEALTH TO REDUCE PREVENTABLE EMERGENCY ROOM TRANSFERS FROM SKILLED NURSING FACILITIES
  • TABLE 43 CASE 3: CONE HEALTH TO REVOLUTIONIZE TELEHEALTH FOR TRANSITION TO CAREGILITY'S UNIVERSAL HEALTH ENGAGEMENT SOLUTIONS
  • TABLE 44 AI TO REDEFINE TREATMENT EFFECTIVENESS AND SAFETY
  • TABLE 45 AI-DRIVEN CHATBOTS AND TELEHEALTH TO ENHANCE MENTAL HEALTH AND CHRONIC DISEASE MANAGEMENT
  • TABLE 46 TELEHEALTH & TELEMEDICINE MARKET: CPT CODES AND REIMBURSEMENT ANALYSIS
  • TABLE 47 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 48 TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 49 TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 50 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR TELEHEALTH KITS, CARTS, AND STATIONS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 51 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 52 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 53 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (THOUSANDS UNITS)
  • TABLE 54 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR CARDIAC MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 55 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 56 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR RESPIRATORY MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 57 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 58 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 59 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR WEIGHT MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 60 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 61 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PULSE OXIMETER DEVICES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 62 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR OTHER PATIENT MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 63 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 64 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 65 TELEHEALTH & TELEMEDICINE EHR-CENTRIC SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 66 TELEHEALTH & TELEMEDICINE NON-EHR-CENTRIC SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 67 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 68 TELEHEALTH & TELEMEDICINE INTEGRATED SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 69 TELEHEALTH & TELEMEDICINE STANDALONE SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 70 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 71 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR REMOTE PATIENT MONITORING PLATFORMS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 72 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR VIRTUAL CARE PLATFORMS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 73 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR VIDEO CONFERENCING PLATFORMS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 74 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR VIRTUAL SITTING & NURSING PLATFORMS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 75 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 76 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR ON-PREMISE DEPLOYMENT MODELS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 77 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR CLOUD-BASED DEPLOYMENT MODELS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 78 TELEHEALTH & TELEMEDICINE SERVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 79 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 80 TELEHEALTH & TELEMEDICINE MARKET FOR CLINICAL CARE MANAGEMENT, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 81 TELEHEALTH & TELEMEDICINE MARKET FOR PREVENTIVE CARE MANAGEMENT, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 82 TELEHEALTH & TELEMEDICINE MARKET FOR DIAGNOSTICS & TREATMENT, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 83 TELEHEALTH & TELEMEDICINE MARKET FOR REMOTE PATIENT MONITORING/ PATIENT MONITORING, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 84 TELEHEALTH & TELEMEDICINE MARKET FOR REHABILITATION & RECOVERY, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 85 TELEHEALTH & TELEMEDICINE MARKET FOR ADMINISTRATIVE, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 86 TELEHEALTH & TELEMEDICINE MARKET FOR ANALYTICS & REPORTING, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 87 TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT ENGAGEMENT, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 88 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 89 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 90 TELEHEALTH & TELEMEDICINE MARKET FOR PRIMARY CARE, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 91 TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 92 TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 93 TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 94 TELEHEALTH & TELEMEDICINE MARKET FOR TELECARDIOLOGY, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 95 TELEHEALTH & TELEMEDICINE MARKET FOR TELENEUROLOGY, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 96 TELEHEALTH & TELEMEDICINE MARKET FOR DIABETES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 97 TELEHEALTH & TELEMEDICINE MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 98 TELEHEALTH & TELEMEDICINE MARKET FOR HYPERTENSION, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 99 TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 100 TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 101 TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 102 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER SPECIALTY CARE APPLICATIONS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 103 TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 104 TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL SITTING & NURSING, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 105 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 106 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 107 TELEHEALTH & TELEMEDICINE MARKET FOR PEDIATRICS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 108 TELEHEALTH & TELEMEDICINE MARKET FOR ADULTS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 109 TELEHEALTH & TELEMEDICINE MARKET FOR GERIATRICS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 110 TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 111 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 112 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 113 TELEHEALTH & TELEMEDICINE MARKET FOR HOSPITALS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 114 TELEHEALTH & TELEMEDICINE MARKET FOR AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 115 TELEHEALTH & TELEMEDICINE MARKET FOR LONG-TERM CARE & ASSISTED LIVING FACILITIES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 116 TELEHEALTH & TELEMEDICINE MARKET FOR HOME HEALTHCARE, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 117 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 118 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 119 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 120 TELEHEALTH & TELEMEDICINE MARKET FOR PUBLIC HEALTHCARE PAYERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 121 TELEHEALTH & TELEMEDICINE MARKET FOR PRIVATE HEALTHCARE PAYERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 122 TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 123 TELEHEALTH & TELEMEDICINE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 124 TELEHEALTH & TELEMEDICINE MARKET FOR MEDTECH COMPANIES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 125 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 126 TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 127 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 128 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 129 NORTH AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 130 NORTH AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 131 NORTH AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 132 NORTH AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 133 NORTH AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 134 NORTH AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 135 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 136 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 137 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 138 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 139 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 140 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 141 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 142 US: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 143 US: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 144 US: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 145 US: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 146 US: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 147 US: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 148 US: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 149 US: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 150 US: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 151 US: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 152 US: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 153 US: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 154 US: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 155 US: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 156 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 157 CANADA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 158 CANADA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 159 CANADA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 160 CANADA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 161 CANADA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 162 CANADA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 163 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 164 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 165 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 166 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 167 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 168 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 169 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 170 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 171 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 172 EUROPE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 173 EUROPE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 174 EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 175 EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 176 EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 177 EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 178 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 179 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 180 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 181 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 182 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 183 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 184 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 185 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 186 GERMANY: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 187 GERMANY: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 188 GERMANY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 189 GERMANY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 190 GERMANY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 191 GERMANY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 192 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 193 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 194 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 195 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 196 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 197 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 198 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 199 UK: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 200 UK: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 201 UK: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 202 UK: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 203 UK: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 204 UK: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 205 UK: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 206 UK: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 207 UK: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 208 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 209 UK: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 210 UK: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 211 UK: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 212 UK: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 213 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 214 FRANCE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 215 FRANCE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 216 FRANCE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 217 FRANCE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 218 FRANCE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 219 FRANCE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 220 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 221 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 222 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 223 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 224 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 225 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 226 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 227 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 228 ITALY: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 229 ITALY: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 230 ITALY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 231 ITALY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 232 ITALY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 233 ITALY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 234 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 235 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 236 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 237 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 238 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 239 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 240 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 241 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 242 SPAIN: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 243 SPAIN: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 244 SPAIN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 245 SPAIN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 246 SPAIN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 247 SPAIN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 248 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 249 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 250 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 251 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 252 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 253 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 254 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 255 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 256 REST OF EUROPE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 257 REST OF EUROPE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 258 REST OF EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 259 REST OF EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 260 REST OF EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 261 REST OF EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 262 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 263 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 264 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 265 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 266 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 267 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 268 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 269 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 270 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 271 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 272 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 273 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 274 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 275 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 276 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 277 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 278 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 279 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 280 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 281 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 282 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 283 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 284 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 285 CHINA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 286 CHINA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 287 CHINA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 288 CHINA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 289 CHINA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 290 CHINA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 291 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 292 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 293 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 294 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 295 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 296 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 297 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 298 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 299 JAPAN: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 300 JAPAN: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 301 JAPAN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 302 JAPAN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 303 JAPAN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 304 JAPAN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 305 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 306 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 307 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 308 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 309 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 310 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 311 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 312 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 313 INDIA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 314 INDIA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 315 INDIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 316 INDIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 317 INDIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 318 INDIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 319 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 320 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 321 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 322 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 323 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 324 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 325 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 326 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 327 AUSTRALIA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 328 AUSTRALIA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 329 AUSTRALIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 330 AUSTRALIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 331 AUSTRALIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 332 AUSTRALIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 333 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 334 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 335 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 336 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 337 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 338 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 339 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 340 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 341 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 342 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 343 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 344 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 345 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 346 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 347 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 348 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 349 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 350 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 351 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 352 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 353 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 354 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 355 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 356 LATIN AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 357 LATIN AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 358 LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 359 LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 360 LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 361 LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 362 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 363 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 364 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 365 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 366 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 367 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 368 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 369 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 370 BRAZIL: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 371 BRAZIL: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 372 BRAZIL: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 373 BRAZIL: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 374 BRAZIL: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 375 BRAZIL: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 376 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 377 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 378 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 379 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 380 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 381 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 382 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 383 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 384 MEXICO: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 385 MEXICO: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 386 MEXICO: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 387 MEXICO: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 388 MEXICO: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 389 MEXICO: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 390 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 391 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 392 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 393 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 394 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 395 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 396 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 397 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 398 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 399 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 400 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 401 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 402 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 403 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 404 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 405 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 406 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 407 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 408 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 409 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 410 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 411 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 412 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 413 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 414 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 415 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 416 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 417 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 418 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 419 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 420 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 421 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 422 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 423 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 424 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 425 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 426 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 427 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 428 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 429 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 430 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 431 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 432 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 433 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 434 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 435 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 436 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 437 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 438 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 439 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 440 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 441 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 442 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 443 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
  • TABLE 444 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
  • TABLE 445 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 446 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
  • TABLE 447 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
  • TABLE 448 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 449 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 450 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
  • TABLE 451 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 452 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 453 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 454 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN TELEHEALTH & TELEMEDICINE MARKET, JANUARY 2021-JANUARY 2025
  • TABLE 455 TELEHEALTH & TELEMEDICINE MARKET: DEGREE OF COMPETITION
  • TABLE 456 TELEHEALTH & TELEMEDICINE MARKET: REGION FOOTPRINT
  • TABLE 457 TELEHEALTH & TELEMEDICINE MARKET: FUNCTION FOOTPRINT
  • TABLE 458 TELEHEALTH & TELEMEDICINE MARKET: APPLICATION FOOTPRINT
  • TABLE 459 TELEHEALTH & TELEMEDICINE MARKET: COMPONENT FOOTPRINT
  • TABLE 460 TELEHEALTH & TELEMEDICINE MARKET: END-USER FOOTPRINT
  • TABLE 461 TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 462 TELEHEALTH & TELEMEDICINE MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 463 TELEHEALTH & TELEMEDICINE MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 464 TELEHEALTH & TELEMEDICINE MARKET: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 465 TELEHEALTH & TELEMEDICINE MARKET: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 466 TELEHEALTH & TELEMEDICINE MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 467 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 468 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 469 MEDTRONIC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 470 MEDTRONIC: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 471 TELADOC HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 472 TELADOC HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 473 TELADOC HEALTH, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 474 TELADOC HEALTH, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 475 CISCO SYSTEMS, INC.: COMPANY OVERVIEW
  • TABLE 476 CISCO SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 477 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 478 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 479 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 480 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 481 ZOOM COMMUNICATIONS, INC.: COMPANY OVERVIEW
  • TABLE 482 ZOOM COMMUNICATIONS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 483 ZOOM COMMUNICATIONS, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 484 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 485 GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 486 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 487 GE HEALTHCARE: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 488 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
  • TABLE 489 EPIC SYSTEMS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 490 EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 491 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 492 ORACLE: COMPANY OVERVIEW
  • TABLE 493 ORACLE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 494 ORACLE: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 495 ORACLE: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 496 DOXIMITY, INC.: COMPANY OVERVIEW
  • TABLE 497 DOXIMITY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 498 DOXIMITY, INC.: PRODUCT ENHANCEMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 499 DOXIMITY, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 500 DOXIMITY, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 501 AMERICAN WELL: COMPANY OVERVIEW
  • TABLE 502 AMERICAN WELL: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 503 AMERICAN WELL: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 504 AMERICAN WELL: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 505 AMERICAN WELL: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 506 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 507 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 508 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 509 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 510 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.): COMPANY OVERVIEW
  • TABLE 511 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.): PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 512 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.): DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 513 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.): OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 514 AMC HEALTH: COMPANY OVERVIEW
  • TABLE 515 AMC HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 516 AMC HEALTH: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 517 TELESPECIALISTS: COMPANY OVERVIEW
  • TABLE 518 TELESPECIALISTS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 519 TELESPECIALISTS: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 520 TELESPECIALISTS: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 521 TELESPECIALISTS: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 522 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): COMPANY OVERVIEW
  • TABLE 523 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 524 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 525 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): DEALS, JANUARY 2021- JANUARY 2025
  • TABLE 526 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 527 CAREGILITY: COMPANY OVERVIEW
  • TABLE 528 CAREGILITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 529 CAREGILITY: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 530 CAREGILITY: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 531 CAREGILITY: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 532 CVS HEALTH: COMPANY OVERVIEW
  • TABLE 533 CVS HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 534 CVS HEALTH: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 535 CVS HEALTH: DEALS, JANUARY 2021- JANUARY 2025
  • TABLE 536 EVERNORTH HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 537 EVERNORTH HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 538 EVERNORTH HEALTH, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 539 ELATION: COMPANY OVERVIEW
  • TABLE 540 ELATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 541 ELATION: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 542 IRON BOW TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 543 IRON BOW TECHNOLOGIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 544 TIMEDOC, INC.: COMPANY OVERVIEW
  • TABLE 545 CEREBRAL INC.: COMPANY OVERVIEW
  • TABLE 546 KINDBODY: COMPANY OVERVIEW
  • TABLE 547 TRANSACARENT: COMPANY OVERVIEW
  • TABLE 548 CARESIMPLE INC.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 TELEHEALTH & TELEMEDICINE MARKET SEGMENTATION & GEOGRAPHICAL SPREAD
  • FIGURE 2 TELEHEALTH & TELEMEDICINE MARKET: YEARS CONSIDERED
  • FIGURE 3 TELEHEALTH & TELEMEDICINE MARKET: RESEARCH DESIGN
  • FIGURE 4 TELEHEALTH & TELEMEDICINE MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 TELEHEALTH & TELEMEDICINE MARKET: KEY SOURCES OF PRIMARY DATA
  • FIGURE 6 TELEHEALTH & TELEMEDICINE MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 TELEHEALTH & TELEMEDICINE MARKET: INSIGHTS FROM PRIMARIES
  • FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 9 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 10 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 11 BOTTOM-UP APPROACH: END-USER SPENDING ON TELEHEALTH & TELEMEDICINE
  • FIGURE 12 TELEHEALTH & TELEMEDICINE MARKET: TOP-DOWN APPROACH
  • FIGURE 13 TELEHEALTH & TELEMEDICINE MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2030)
  • FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 15 TELEHEALTH & TELEMEDICINE MARKET: DATA TRIANGULATION
  • FIGURE 16 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2024 VS. 2030 (USD MILLION)
  • FIGURE 17 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2024 VS. 2030 (USD MILLION)
  • FIGURE 18 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)
  • FIGURE 19 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2024 VS. 2030 (USD MILLION)
  • FIGURE 20 TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
  • FIGURE 21 TELEHEALTH & TELEMEDICINE MARKET: REGIONAL SNAPSHOT
  • FIGURE 22 NEED TO IMPROVE ACCESSIBILITY AND REDUCE HEALTHCARE EXPENSES TO DRIVE MARKET
  • FIGURE 23 US AND HEALTHCARE PROVIDERS COMMANDED LARGEST MARKET SHARE IN 2023
  • FIGURE 24 CHINA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030
  • FIGURE 25 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 26 TELEHEALTH & TELEMEDICINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 27 INCREASE IN POPULATION, 2022 VS. 2030 VS. 2050 (MILLION)
  • FIGURE 28 US: MEDICARE-CERTIFIED AMBULATORY SURGERY CENTERS, BY STATE (SEPTEMBER 2024)
  • FIGURE 29 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009-2024
  • FIGURE 30 US: MEDIAN HEALTHCARE DATA BREACH SIZE, 2009-2024
  • FIGURE 31 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009-2023
  • FIGURE 32 TELEHEALTH & TELEMEDICINE MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • FIGURE 33 TELEHEALTH & TELEMEDICINE MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 34 TELEHEALTH & TELEMEDICINE MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 35 TELEHEALTH & TELEMEDICINE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 36 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
  • FIGURE 37 KEY BUYING CRITERIA FOR TOP THREE COMPONENTS
  • FIGURE 38 GLOBAL PATENT PUBLICATION TRENDS IN TELEHEALTH & TELEMEDICINE, 2015-2024
  • FIGURE 39 JURISDICTION AND TOP APPLICANT ANALYSIS IN TELEHEALTH & TELEMEDICINE (2024)
  • FIGURE 40 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR TELEHEALTH & TELEMEDICINE (JANUARY 2015-DECEMBER 2024)
  • FIGURE 41 FUNDING AND NUMBER OF DEALS IN TELEHEALTH & TELEMEDICINE MARKET
  • FIGURE 42 POTENTIAL OF AI/GEN AI IN TELEHEALTH & TELEMEDICINE MARKET
  • FIGURE 43 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT
  • FIGURE 44 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT
  • FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS IN TELEHEALTH & TELEMEDICINE MARKET, 2019-2023 (USD MILLION)
  • FIGURE 46 MARKET SHARE ANALYSIS OF KEY PLAYERS IN TELEHEALTH & TELEMEDICINE MARKET (2023)
  • FIGURE 47 TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 48 TELEHEALTH & TELEMEDICINE MARKET: COMPANY FOOTPRINT
  • FIGURE 49 TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 50 EV/EBITDA OF KEY VENDORS, 2024
  • FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024
  • FIGURE 52 TELEHEALTH & TELEMEDICINE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • FIGURE 53 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 54 TELADOC HEALTH, INC.: COMPANY SNAPSHOT
  • FIGURE 55 CISCO SYSTEMS, INC.: COMPANY SNAPSHOT
  • FIGURE 56 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 57 ZOOM COMMUNICATIONS, INC.: COMPANY SNAPSHOT
  • FIGURE 58 GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 59 ORACLE: COMPANY SNAPSHOT
  • FIGURE 60 DOXIMITY, INC.: COMPANY SNAPSHOT
  • FIGURE 61 AMERICAN WELL: COMPANY SNAPSHOT
  • FIGURE 62 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
  • FIGURE 63 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): COMPANY SNAPSHOT
  • FIGURE 64 CVS HEALTH: COMPANY SNAPSHOT
  • FIGURE 65 EVERNORTH HEALTH, INC.: COMPANY SNAPSHOT